Author name: Professor Paul Knoepfler, Ph.D.

Paul Knoepfler, Ph.D. is a Professor at UC Davis School of Medicine in Cell Biology and Human Anatomy. His lab does research on stem cells and cancer, especially from an epigenomic angle. He also has been working on policy and ethics matters for many years. The author of 3 books, he also has a popular TED talk on designer babies.

Weekly reads: Prasad successor, Sammy Hagar stem cells, more on OSK trial, Finnish speaker needed

Vinay Prasad

Vinay Prasad has only less than two  weeks left at the FDA atop CBER. I’ve been trying to imagine where CBER goes from here after he exits. It feels like FDA Commissioner Marty Makary and RFK Jr. will likely be the real leaders of CBER moving forward on key decisions. Under that pressure, will the […]

Weekly reads: Prasad successor, Sammy Hagar stem cells, more on OSK trial, Finnish speaker needed Read More »

Weekly reads: federal stem cell charges disappear, SCBEM ethics, diet & MYCN cancer, how to make a nose

South-Carolina-Representative-Stephen-Goldfinch

Over the years people have asked me why those selling unproven stem cells and more recently peptides haven’t faced more pushback. Cases do arise, but they often go nowhere. Civil cases like patient lawsuits against stem cell clinics are often settled. These are generally subject to confidentiality agreements. On the peptide front, we’ll have to

Weekly reads: federal stem cell charges disappear, SCBEM ethics, diet & MYCN cancer, how to make a nose Read More »

Landmark federal indictment for pop peptides alleged ‘scheme’ even as RFK Jr. may soon un-ban some

Justin Watkins, pop peptides

It’s been a whirlwind of news about pop peptides like BPC-157 and now one of the first indictments related to marketing of these unproven drugs at a clinic. While RFK Jr. may want to unleash previously banned peptides on the public, it hasn’t happened yet. Those still selling these unproven peptides anyway have had to

Landmark federal indictment for pop peptides alleged ‘scheme’ even as RFK Jr. may soon un-ban some Read More »

Weekly reads: 1st FDA-approved CIRM supported therapy, asymmetric histone inheritance, stem cell retraction

CIRM

We recently saw exciting news with the first CIRM-funded therapy garnering FDA approval. Before we jump into that and other news and new publications, a reminder that my lab is still crowdfunding to support our brain tumor research in these tough funding times. Please consider making a tax-deductible gift to give more hope for kids

Weekly reads: 1st FDA-approved CIRM supported therapy, asymmetric histone inheritance, stem cell retraction Read More »

My favorite weird & not-so-weird but cool science pictures from 16 years of The Niche: Part 1

flesh-faced robots

I love science pictures. Even when I was a kid, images of science really struck me. I’ve been doing The Niche now for 16 years and come across many unusual pictures during that time. It’s hard to imagine that I started this site in 2010. What a different world that was. In some ways, it

My favorite weird & not-so-weird but cool science pictures from 16 years of The Niche: Part 1 Read More »

Weekly reads: Gattaca stack, animal sacks, custom iPS cells, ImmunityBio FDA warning, mouse cloning limit

Gattaca stack

You’ve probably heard of the film Gattaca, but what is a Gattaca stack? The first thing that came to mind was a peptide stack (oh no!). That is where people take groups of unproven peptides together, usually by injection. Yeah, not a great idea. So, what’s the Gattaca stack? As someone following the area of

Weekly reads: Gattaca stack, animal sacks, custom iPS cells, ImmunityBio FDA warning, mouse cloning limit Read More »

Weekly reads: the thymus and aging, Aspen upbeat 1 year data, paired organoids

Thymus, thymus and aging

Connections between the thymus and aging are growing. Let’s start with that interesting area of research. The thymus and aging In Histology class at the med school here we teach that the thymus just naturally involutes. It mostly turns to adipose tissue with age, which is a depressing thought. A new paper suggests that there

Weekly reads: the thymus and aging, Aspen upbeat 1 year data, paired organoids Read More »

FDA investigating: US patient dies after use of placental extract Laennec, Russian med student also died

Laennec

The FDA is reporting that someone in the US died after use of a regenerative medicine product imported from Japan called Laennec. Here’s the FDA report on the death related to Laennec. The agency advisory is titled: Patient and Consumer Warning about Potential Serious Risks of Harm following Use of Unapproved Products from Human Cells

FDA investigating: US patient dies after use of placental extract Laennec, Russian med student also died Read More »

Weekly reads: Prasad exit & replacement, FDA on Leucovorin, Mexico’s stem cell clinic industry

FDA Cell & Gene Therapy Roundtable, Prasad Exit

Vinay Prasad, the outgoing CBER Director (right), with Commissioner Marty Makary, at a cell and gene therapy roundtable last year. Vinay Prasad is leaving the FDA again in a few weeks. As CBER Director, Prasad was all over the place on how he handled oversight of biologics. He and Commissioner Marty Makary promised flexibility from

Weekly reads: Prasad exit & replacement, FDA on Leucovorin, Mexico’s stem cell clinic industry Read More »

RFK Jr. tells Joe Rogan he’s used peptides & will un-ban them soon: why it’s a terrible idea

RFK Jr.

RFK Jr. might be the biggest peptides fan of all. Or it could be the compounding pharmacy industry or Joe Rogan. For a few years, compounders were profiting from marketing the most popular of these unproven peptide drugs (what I call “pop peptides”). The FDA put a halt to that in 2023. The agency at

RFK Jr. tells Joe Rogan he’s used peptides & will un-ban them soon: why it’s a terrible idea Read More »